CY 2017 OPPS/ASC PROPOSED RULE		
"Addendum O:  New Category I and III CPT Codes Effective January 1, 2017"		
CPT codes and descriptions only are copyright 2016 American Medical Association.  All Rights Reserved.  Applicable FARS/DFARS Apply. 		
"NOTE 1:  As discussed in sections III.A. (Proposed OPPS Treatment of New CPT and Level II HCPCS) and XII.B. (Proposed Treatment of New Codes) of the CY 2017 OPPS/ASC proposed rule, we are requesting comments on the new CPT codes below.  Specifically, we are requesting comments on the OPPS status indicator and APC assignments, as well as the ASC payment indicator assignments.  The proposed CY 2017 payment rates for these codes can be found in OPPS Addendum B, ASC Addendum AA, and ASC Addendum BB of this proposed rule, which are available via the Internet on the CMS Web site."		
"NOTE 2:  Comments will NOT be accepted for new Category I CPT  laboratory codes that are not assigned to ""NP"" comment indicator.  Comments to these codes must be submitted at the Clinical Laboratory Fee Schedule (CLFS) Public Meeting, which is scheduled for July 18, 2016."		
CY 2017 OPPS/ASC Proposed Rule               5-Digit  Placeholder Code	Long Descriptor	Comment Indicator (CI)
22X81	"Insertion of interbody biomechanical device(s) (eg, synthetic cage, mesh) with integral anterior instrumentation for device anchoring (eg, screws, flanges), when performed, to intervertebral disc space in conjunction with interbody arthrodesis, each interspace (List separately in addition to code for primary procedure)"	NP
22X82	"Insertion of intervertebral biomechanical device(s) (eg, synthetic cage, mesh) with integral anterior instrumentation for device anchoring (eg, screws, flanges), when performed, to vertebral corpectomy(ies) (vertebral body resection, partial or complete) defect, in conjunction with interbody arthrodesis, each contiguous defect (List separately in addition to code for primary procedure)"	NP
22X83	"Insertion of intervertebral biomechanical device(s) (eg, synthetic cage, mesh, methylmethacrylate) to intervertebral disc space or vertebral body defect without interbody arthrodesis, each contiguous defect (List separately in addition to code for primary procedure)"	NP
228X1	"Insertion of interlaminar/interspinous process stabilization/distraction device, without fusion, including image guidance when performed, with open decompression, lumbar; single level"	NP
228X2	"Insertion of interlaminar/interspinous process stabilization/distraction device, without fusion, including image guidance when performed, with open decompression, lumbar; second level (List separately in addition to code for primary procedure)"	NP
228X4	"Insertion of interlaminar/interspinous process stabilization/distraction device, without open decompression or fusion, including image guidance when performed, lumbar; single level"	NP
228X5	"Insertion of interlaminar/interspinous process stabilization/distraction device, without open decompression or fusion, including image guidance when performed, lumbar; second level (List separately in addition to code for primary procedure)"	NP
271X1	"Closed treatment of posterior pelvic ring fracture(s), dislocation(s), diastasis or subluxation of the ilium, sacroiliac joint, and/or sacrum, with or without anterior pelvic ring fracture(s) and/or dislocation(s) of the pubic symphysis and/or superior/inferior rami, unilateral or bilateral; without manipulation"	NP
271X2	"Closed treatment of posterior pelvic ring fracture(s), dislocation(s), diastasis or subluxation of the ilium, sacroiliac joint, and/or sacrum, with or without anterior pelvic ring fracture(s) and/or dislocation(s) of the pubic symphysis and/or superior/inferior rami, unilateral or bilateral; with manipulation, requiring more than local anesthesia (ie, general anesthesia, moderate sedation, spinal/epidural)"	NP
282X1	"Hallux rigidus correction with cheilectomy, debridement and capsular release of the first metatarsophalangeal joint; with implant"	NP
282X2	"Correction, hallux valgus (bunionectomy), with sesamoidectomy, when performed; with proximal metatarsal osteotomy, any method"	NP
317X1	"Laryngoscopy, flexible; with ablation or destruction of lesion(s) with laser, unilateral"	NP
317X2	"Laryngoscopy, flexible; with therapeutic injection(s) (eg, chemodenervation agent or corticosteroid, injected percutaneous, transoral, or via endoscope channel), unilateral"	NP
317X3	"Laryngoscopy, flexible; with injection(s) for augmentation (eg, percutaneous, transoral), unilateral"	NP
315X1	"Laryngoplasty; for laryngeal stenosis, with graft, without indwelling stent placement, younger than 12 years of age"	NP
315X2	"Laryngoplasty; for laryngeal stenosis, with graft, without indwelling stent placement, age 12 years or older"	NP
315X3	"Laryngoplasty; for laryngeal stenosis, with graft, with indwelling stent placement, younger than 12 years of age"	NP
315X4	"Laryngoplasty; for laryngeal stenosis, with graft, with indwelling stent placement, age 12 years or older"	NP
315X5	"Laryngoplasty, medialization, unilateral"	NP
315X6	Cricotracheal resection	NP
333X3	"Percutaneous transcatheter closure of the left atrial appendage with endocardial implant, including fluoroscopy, transseptal puncture, catheter placement(s), left atrial angiography, left atrial appendage angiography, when performed, and radiological supervision and interpretation"	NP
334X1	"Valvuloplasty, aortic valve, open, with cardiopulmonary bypass; simple (ie, valvotomy, debridement, debulking, and/or simple commissural resuspension)"	NP
334X2	"Valvuloplasty, aortic valve, open, with cardiopulmonary bypass; complex (eg, leaflet extension, leaflet resection, leaflet reconstruction, or annuloplasty)"	NP
364X1	"Partial exchange transfusion, blood, plasma or crystalloid necessitating the skill of a physician or other qualified health care professional, newborn"	NP
36X41	"Endovenous ablation therapy of incompetent vein, extremity, inclusive of all imaging guidance and monitoring, percutaneous, mechanochemical; first vein treated"	NP
364X2	"Endovenous ablation therapy of incompetent vein, extremity, inclusive of all imaging guidance and monitoring, percutaneous, mechanochemical; subsequent vein(s) treated in a single extremity, each through separate access sites (List separately in addition to code for primary procedure)"	NP
369X1	"Introduction of needle(s) and/or catheter(s), dialysis circuit, with diagnostic angiography of the dialysis circuit, including all direct puncture(s) and catheter placement(s), injection(s) of contrast, all necessary imaging from the arterial anastomosis and adjacent artery through entire venous outflow including the inferior or superior vena cava, fluoroscopic guidance, radiological supervision and interpretation and image documentation and report"	NP
369X2	"Introduction of needle(s) and/or catheter(s), dialysis circuit, with diagnostic angiography of the dialysis circuit, including all direct puncture(s) and catheter placement(s), injection(s) of contrast, all necessary imaging from the arterial anastomosis and adjacent artery through entire venous outflow including the inferior or superior vena cava, fluoroscopic guidance, radiological supervision and interpretation and image documentation and report; with transluminal balloon angioplasty, peripheral dialysis segment, including all imaging and radiological supervision and interpretation necessary to perform the angioplasty"	NP
369X3	"Introduction of needle(s) and/or catheter(s), dialysis circuit, with diagnostic angiography of the dialysis circuit, including all direct puncture(s) and catheter placement(s), injection(s) of contrast, all necessary imaging from the arterial anastomosis and adjacent artery through entire venous outflow including the inferior or superior vena cava, fluoroscopic guidance, radiological supervision and interpretation and image documentation and report; with transcatheter placement of intravascular stent(s) peripheral dialysis segment, including all imaging and radiological supervision and interpretation necessary to perform the stenting, and all angioplasty within the peripheral dialysis segment"	NP
369X4	"Percutaneous transluminal mechanical thrombectomy and/or infusion for thrombolysis, dialysis circuit, any method, including all imaging and radiological supervision and interpretation, diagnostic angiography, fluoroscopic guidance, catheter placement(s), and intraprocedural pharmacological thrombolytic injection(s)"	NP
369X5	"Percutaneous transluminal mechanical thrombectomy and/or infusion for thrombolysis, dialysis circuit, any method, including all imaging and radiological supervision and interpretation, diagnostic angiography, fluoroscopic guidance, catheter placement(s), and intraprocedural pharmacological thrombolytic injection(s); with transluminal balloon angioplasty, peripheral dialysis segment, including all imaging and radiological supervision and interpretation necessary to perform the angioplasty"	NP
369X6	"Percutaneous transluminal mechanical thrombectomy and/or infusion for thrombolysis, dialysis circuit, any method, including all imaging and radiological supervision and interpretation, diagnostic angiography, fluoroscopic guidance, catheter placement(s), and intraprocedural pharmacological thrombolytic injection(s); with transcatheter placement of an intravascular stent(s), peripheral dialysis segment, including all imaging and radiological supervision and interpretation necessary to perform the stenting, and all angioplasty within the peripheral dialysis circuit"	NP
369X7	"Transluminal balloon angioplasty, central dialysis segment, performed through dialysis circuit, including all imaging and radiological supervision and interpretation required to perform the angioplasty (List separately in addition to code for primary procedure)"	NP
369X8	"Transcatheter placement of an intravascular stent(s), central dialysis segment, performed through dialysis circuit, including all imaging radiological supervision and interpretation required to perform the stenting, and all angioplasty in the central dialysis segment (List separately in addition to code for primary procedure)"	NP
369X9	"Dialysis circuit permanent vascular embolization or occlusion (including main circuit or any accessory veins), endovascular, including all imaging and radiological supervision and interpretation necessary to complete the intervention (List separately in addition to code for primary procedure)"	NP
372X1	"Transluminal balloon angioplasty (except lower extremity artery(s) for occlusive disease, intracranial, coronary, pulmonary, or dialysis circuit), open or percutaneous, including all imaging and radiological supervision and interpretation necessary to perform the angioplasty within the same artery; initial artery"	NP
372X2	"Transluminal balloon angioplasty (except lower extremity artery(s) for occlusive disease, intracranial, coronary, pulmonary, or dialysis circuit), open or percutaneous, including all imaging and radiological supervision and interpretation necessary to perform the angioplasty within the same artery; each additional artery (List separately in addition to code for primary procedure)"	NP
372X3	"Transluminal balloon angioplasty (except dialysis circuit), open or percutaneous, including all imaging and radiological supervision and interpretation necessary to perform the angioplasty within the same vein; initial vein"	NP
372X4	"Transluminal balloon angioplasty (except dialysis circuit), open or percutaneous, including all imaging and radiological supervision and interpretation necessary to perform the angioplasty within the same vein; each additional vein (List separately in addition to code for primary procedure)"	NP
432X1	"Laparoscopy, surgical, esophageal sphincter augmentation procedure, placement of sphincter augmentation device (ie, magnetic band), including cruroplasty when performed"	NP
432X2	Removal of esophageal sphincter augmentation device	NP
585X1	"Laparoscopy, surgical, ablation of uterine fibroid(s) including intraoperative ultrasound guidance and monitoring, radiofrequency"	NP
623X5	"Injection(s), of diagnostic or therapeutic substance(s) (eg, anesthetic, antispasmodic, opioid, steroid, other solution), not including neurolytic substances, including needle or catheter placement, interlaminar epidural or subarachnoid, cervical or thoracic; without imaging guidance"	NP
623X6	"Injection(s), of diagnostic or therapeutic substance(s) (eg, anesthetic, antispasmodic, opioid, steroid, other solution), not including neurolytic substances, including needle or catheter placement, interlaminar epidural or subarachnoid, cervical or thoracic; with imaging guidance (ie, fluoroscopy or CT)"	NP
623X7	"Injection(s), of diagnostic or therapeutic substance(s) (eg, anesthetic, antispasmodic, opioid, steroid, other solution), not including neurolytic substances, including needle or catheter placement, interlaminar epidural or subarachnoid, lumbar or sacral (caudal); without imaging guidance"	NP
623X8	"Injection(s), of diagnostic or therapeutic substance(s) (eg, anesthetic, antispasmodic, opioid, steroid, other solution), not including neurolytic substances, including needle or catheter placement, interlaminar epidural or subarachnoid, lumbar or sacral (caudal); with imaging guidance (ie, fluoroscopy or CT)"	NP
623X9	"Injection(s), including indwelling catheter placement, continuous infusion or intermittent bolus, of diagnostic or therapeutic substance(s) (eg, anesthetic, antispasmodic, opioid, steroid, other solution), not including neurolytic substances, interlaminar epidural or subarachnoid, cervical or thoracic; without imaging guidance"	NP
62X10	"Injection(s), including indwelling catheter placement, continuous infusion or intermittent bolus, of diagnostic or therapeutic substance(s) (eg, anesthetic, antispasmodic, opioid, steroid, other solution), not including neurolytic substances, interlaminar epidural or subarachnoid, cervical or thoracic; with imaging guidance (ie, fluoroscopy or CT)"	NP
62X11	"Injection(s), including indwelling catheter placement, continuous infusion or intermittent bolus, of diagnostic or therapeutic substance(s) (eg, anesthetic, antispasmodic, opioid, steroid, other solution), not including neurolytic substances, interlaminar epidural or subarachnoid, lumbar or sacral (caudal); without imaging guidance"	NP
62X12	"Injection(s), including indwelling catheter placement, continuous infusion or intermittent bolus, of diagnostic or therapeutic substance(s) (eg, anesthetic, antispasmodic, opioid, steroid, other solution), not including neurolytic substances, interlaminar epidural or subarachnoid, lumbar or sacral (caudal); with imaging guidance (ie, fluoroscopy or CT)"	NP
630X1	"Endoscopic decompression of spinal cord, nerve root(s), including laminotomy, partial facetectomy, foraminotomy, discectomy and/or excision of herniated intervertebral disc, 1 interspace, lumbar"	NP
767X1	"Ultrasound, abdominal aorta, real time with image documentation, screening study for abdominal aortic aneurysm (AAA)"	NP
770X1	"Diagnostic mammography, including computer-aided detection (CAD) when performed; unilateral"	NP
770X2	"Diagnostic mammography, including computer-aided detection (CAD) when performed; bilateral"	NP
770X3	"Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (CAD) when performed"	NP
803X1	"Drug test(s), presumptive, any number of drug classes, qualitative,  any number of devices or procedures, (eg, immunoassay) capable of being read by direct optical observation only (eg, dipsticks, cups, cards, cartridges) includes sample validation when performed, per date of service"	
803X2	"Drug test(s), presumptive, any number of drug classes, qualitative,  any number of devices or procedures, (eg, immunoassay) read by instrument assisted direct optical observation (eg, dipsticks, cups, cards, cartridges), includes sample validation when performed, per date of service"	
803X3	"Drug test(s), presumptive, any number of drug classes, qualitative, any number of devices or procedures by instrument chemistry analyzers (eg, utilizing immunoassay [eg, EIA, ELISA, EMIT, FPIA, IA, KIMS, RIA]), chromatography (eg, GC, HPLC), and mass spectrometry either with or without chromatography, (eg, DART, DESI, GC-MS, GC-MS/MS, LC-MS, LC-MS/MS, LDTD, MALDI, TOF) includes sample validation when performed, per date of service"	
813X7	"SEPT9 (Septin9) (eg, colorectal cancer) methylation analysis"	
814X1	"Oncology (high-grade prostate cancer), biochemical assay of four proteins (Total PSA, Free PSA, Intact PSA and human kallikrein-2 [hK2]), utilizing plasma or serum, prognostic algorithm reported as a probability score"	
814X2	"Inherited cardiomyopathy (eg, hypertrophic cardiomyopathy, dilated cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy) genomic sequence analysis panel, must include sequencing of at least 5 genes, including DSG2, MYBPC3, MYH7, PKP2, and TTN"	
814X3	"Fetal chromosomal microdeletion(s) genomic sequence analysis (eg, DiGeorge syndrome, Cri-du-chat syndrome), circulating cell-free fetal DNA in maternal blood"	
814X5	"Cardiac ion channelopathies (eg, Brugada syndrome, long QT syndrome, short QT syndrome, catecholaminergic polymorphic ventricular tachycardia); genomic sequence analysis panel, must include sequencing of at least 10 genes, including ANK2, CASQ2, CAV3, KCNE1, KCNE2, KCNH2, KCNJ2, KCNQ1, RYR2, and SCN5A"	
814X6	"Cardiac ion channelopathies (eg, Brugada syndrome, long QT syndrome, short QT syndrome, catecholaminergic polymorphic ventricular tachycardia); duplication/deletion gene analysis panel, must include analysis of at least 2 genes, including KCNH2 and KCNQ1"	
844XX	"Testosterone; bioavailable, direct measurement (eg, differential precipitation)"	
878XX	"Infectious agent detection by nucleic acid (DNA or RNA); central nervous system pathogen (eg, Neisseria meningitidis, Streptococcus pneumoniae, Listeria, Haemophilus influenzae, E. coli, Streptococcus agalactiae, enterovirus, human parechovirus, herpes simplex virus type 1 and 2, human herpes virus 6, cytomegalovirus, varicella zoster virus, Cryptococcus), includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, multiple types or subtypes, 12-25 targets"	
906X2	"Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use"	NP
922X4	"Fluorescein angiography and indocyanine-green angiography (includes multiframe imaging) performed at the same patient encounter with interpretation and report, unilateral or bilateral"	NP
935X1	"Percutaneous transcatheter closure of paravalvular leak; initial occlusion device, mitral valve"	NP
935X2	"Percutaneous transcatheter closure of paravalvular leak; initial occlusion device, aortic valve"	NP
935X3	Percutaneous transcatheter closure of paravalvular leak; each additional occlusion device (List separately in addition to code for primary procedure)	NP
961X0	"Administration of patient-focused health risk assessment instrument (eg, health hazard appraisal) with scoring and documentation, per standardized instrument"	NP
961X1	"Administration of caregiver-focused health risk assessment instrument (eg, depression inventory) for the benefit of the patient, with scoring and documentation, per standardized instrument"	NP
963XX	Application of on-body injector (includes cannula insertion) for timed subcutaneous injection	NP
97X61	"Physical therapy evaluation: low complexity, requiring these components:A history with no personal factors and/or comorbidities that impact the plan of care;An examination of body system(s) using standardized tests and measures addressing 1-2 elements from any of the following: body structures and functions, activity limitations, and/or participation restrictions;A clinical presentation with stable and/or uncomplicated characteristics; and Clinical decision making of low complexity using standardized patient assessment instrument and/or measurable assessment of functional outcome.Typically, 20 minutes are spent face-to-face with the patient and/or family."	NP
97X62	"Physical therapy evaluation: moderate complexity, requiring these components:A history of present problem with 1-2 personal factors and/or comorbidities that impact the plan of care;An examination of body systems using standardized tests and measures in addressing a total of 3 or more elements from any of the following body structures and functions, activity limitations, and/or participation restrictions;An evolving clinical presentation with changing characteristics; andClinical decision making of moderate complexity using standardized patient assessment instrument and/or measurable assessment of functional outcome.Typically, 30 minutes are spent face-to-face with the patient and/or family."	NP
97X63	"Physical therapy evaluation: high complexity, requiring these components:A history of present problem with 3 or more personal factors and/or comorbidities that impact the plan of care;An examination of body systems using standardized tests and measures addressing a total of 4 or more elements from any of the following: body structures and functions, activity limitations, and/or participation restrictions;A clinical presentation with unstable and unpredictable characteristics; andClinical decision making of high complexity using standardized patient assessment instrument and/or measurable assessment of functional outcome.Typically, 45 minutes are spent face-to-face with the patient and/or family."	NP
97X64	"Re-evaluation of physical therapy established plan of care, requiring these components:An examination including a review of history and use of standardized tests and measures is required; andRevised plan of care using a standardized patient assessment instrument and/or measurable assessment of functional outcomeTypically, 20 minutes are spent face-to-face with the patient and/or family."	NP
97X65	"Occupational therapy evaluation, low complexity, requiring these components:An occupational profile and medical and therapy history, which includes a brief history including review of medical and/or therapy records relating to the presenting problem;An assessment(s) that identifies 1-3 performance deficits (ie, relating to physical, cognitive, or psychosocial skills) that result in activity limitations and/or participation restrictions; andClinical decision making of low complexity, which includes an analysis of the occupational profile, analysis of data from problem-focused assessment(s), and consideration of a limited number of treatment options. Patient presents with no comorbidities that affect occupational performance. Modification of tasks or assistance (eg, physical or verbal) with assessment(s) is not necessary to enable completion of evaluation component.Typically, 30 minutes are spent face-to-face with the patient and/or family."	NP
97X66	"Occupational therapy evaluation, moderate complexity, requiring these components:An occupational profile and medical and therapy history, which includes an expanded review of medical and/or therapy records and additional review of physical, cognitive, or psychosocial history related to current functional performance;An assessment(s) that identifies 3-5 performance deficits (ie, relating to physical, cognitive, or psychosocial skills) that result in activity limitations and/or participation restrictions; andClinical decision making of moderate analytic complexity, which includes an analysis of the occupational profile, analysis of data from detailed assessment(s), and consideration of several treatment options. Patient may present with comorbidities that affect occupational performance. Minimal to moderate modification of tasks or assistance (eg, physical or verbal) with assessment(s) is necessary to enable patient to complete evaluation component.Typically, 45 minutes are spent face-to-face with the patient and/or family."	NP
97X67	"Occupational therapy evaluation, high complexity, requiring these components:An occupational profile and medical and therapy history, which includes review of medical and/or therapy records and extensive additional review of physical, cognitive, or psychosocial history related to current functional performance;An assessment(s) that identify 5 or more performance deficits (ie, relating to physical, cognitive, or psychosocial skills) that result in activity limitations and/or participation restrictions; andClinical decision making of high analytic complexity, which includes an analysis of the patient profile, analysis of data from comprehensive assessment(s), and consideration of multiple treatment options. Patient presents with comorbidities that affect occupational performance. Significant modification of tasks or assistance (eg, physical or verbal) with assessment(s) is necessary to enable patient to complete evaluation component.Typically, 60 minutes are spent face-to-face with the patient and/or family."	NP
97X68	"Re-evaluation of occupational therapy established plan of care, requiring these components:An assessment of changes in patient functional or medical status with revised plan of care;An update to the initial occupational profile to reflect changes in condition or environment that affect future interventions and/or goals; andA revised plan of care. A formal reevaluation is performed when there is a documented change in functional status or a significant change to the plan of care is required.Typically, 30 minutes are spent face-to-face with the patient and/or family."	NP
97X69	"Athletic training evaluation, low complexity requiring these components:A history and physical activity profile with no comorbidities that affect physical activity;An examination of affected body area and other symptomatic or related systems addressing 1-2 elements from any of the following: body structures, physical activity, and/or participation deficiencies; andClinical decision making of low complexity using standardized patient assessment instrument and/or measurable assessment of functional outcome.Typically, XXX minutes are spent face-to-face with the patient and/or family."	NP
97X70	"Athletic training evaluation, moderate complexity, requiring these components:A medical history and physical activity profile with 1-2 comorbidities that affect physical activity;An examination of affected body area and other symptomatic or related systems addressing a total of 3 or more elements from any of the following: body structures, physical activity, and/or participation deficiencies; andClinical decision making of moderate complexity using standardized patient assessment instrument and/or measurable assessment of functional outcome.Typically, XXX minutes are spent face-to-face with the patient and/or family."	NP
97X71	"Athletic training evaluation, high complexity, requiring these components:A medical history and physical activity profile, with 3 or more comorbidities that affect physical activity;A comprehensive examination of body systems using standardized tests and measures addressing a total of 4 or more elements from any of the following: body structures, physical activity, and/or participation deficiencies;Clinical presentation with unstable and unpredictable characteristics; andClinical decision making of high complexity using standardized patient assessment instrument and/or measurable assessment of functional outcome.Typically, XXX minutes are spent face-to-face with the patient and/or family."	NP
97X72	"Reevaluation of athletic training established plan of care requiring these components:An assessment of patient’s current functional status when there is a documented change; andA revised plan of care using a standardized patient assessment instrument and/or measurable assessment of functional outcome with an update in management options, goals, and interventions.Typically, XXX minutes are spent face-to-face with the patient and/or family."	NP
991X1	"Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient’s level of consciousness and physiological status; initial 15 minutes of intra-service time, patient younger than 5 years of age"	NP
991X2	"Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient’s level of consciousness and physiological status; initial 15 minutes of intra-service time, patient age 5 years or older"	NP
991X5	"Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient’s level of consciousness and physiological status; each additional 15 minutes intra-service time (List separately in addition to code for primary service)"	NP
991X3	"Moderate sedation services provided by a physician or other qualified health care professional other than the physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports; initial 15 minutes of intra-service time, patient younger than 5 years of age"	NP
991X4	"Moderate sedation services provided by a physician or other qualified health care professional other than the physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports; initial 15 minutes of intra-service time, patient age 5 years or older"	NP
991X6	Moderate sedation services provided by a physician or other qualified health care professional other than the physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports; each additional 15 minutes intra-service time (List separately in addition to code for primary service)	NP
04X1T	"Creation of subcutaneous pocket with insertion of implantable interstitial glucose sensor, including system activation and patient training"	NP
04X2T	Removal of implantable interstitial glucose sensor from subcutaneous pocket via incision	NP
04X3T	"Removal of implantable interstitial glucose sensor with creation of subcutaneous pocket at different anatomic site and insertion of new implantable sensor, including system activation"	NP
04X4T	"Insertion of aqueous drainage device, without extraocular reservoir, internal approach, into the subconjunctival space; initial device"	NP
04X5T	"Insertion of aqueous drainage device, without extraocular reservoir, internal approach, into the subconjunctival space; each additional device (List separately in addition to code for primary procedure)"	NP
0X11T	"Insertion or replacement of a permanently implantable aortic counterpulsation ventricular assist system, endovascular approach, and programming of sensing and therapeutic parameters; complete system (counterpulsation device, vascular graft, implantable vascular hemostatic seal, mechano-electrical skin interface and subcutaneous electrodes)"	NP
0X12T	"Insertion or replacement of a permanently implantable aortic counterpulsation ventricular assist system, endovascular approach, and programming of sensing and therapeutic parameters; aortic counterpulsation device and vascular hemostatic seal"	NP
0X13T	"Insertion or replacement of a permanently implantable aortic counterpulsation ventricular assist system, endovascular approach, and programming of sensing and therapeutic parameters; mechano-electrical skin interface"	NP
0X14T	"Insertion or replacement of a permanently implantable aortic counterpulsation ventricular assist system, endovascular approach, and programming of sensing and therapeutic parameters; subcutaneous electrode"	NP
0X15T	"Removal of permanently implantable aortic counterpulsation ventricular assist system; complete system (aortic counterpulsation device, vascular hemostatic seal, mechano-electrical skin interface and electrodes)"	NP
0X16T	Removal of permanently implantable aortic counterpulsation ventricular assist system; aortic counterpulsation device and vascular hemostatic seal	NP
0X17T	Removal of permanently implantable aortic counterpulsation ventricular assist system; mechano-electrical skin interface	NP
0X18T	Removal of permanently implantable aortic counterpulsation ventricular assist system; subcutaneous electrode	NP
0X20T	"Relocation of skin pocket with replacement of implanted aortic counterpulsation ventricular assist device, mechano-electrical skin interface and electrodes"	NP
0X21T	"Repositioning of previously implanted aortic counterpulsation ventricular assist device, subcutaneous electrode"	NP
0X22T	"Repositioning of previously implanted aortic counterpulsation ventricular assist device, subcutaneous electrode; aortic counterpulsation device"	NP
0X23T	"Programming device evaluation (in person) with iterative adjustment of the implantable mechano-electrical skin interface and/or external driver to test the function of the device and select optimal permanent programmed values with analysis, including review and report, implantable aortic counterpulsation ventricular assist system, per day"	NP
0X24T	"Interrogation device evaluation (in person) with analysis, review and report, includes connection, recording and disconnection per patient encounter, implantable aortic counterpulsation ventricular assist system, per day"	NP
0X66T	"Visual evoked potential, testing for glaucoma, with interpretation and report "	NP
05X1T	Suprachoroidal injection of a pharmacologic agent (does not include supply of medication)	NP
046XT	"Insertion of chest wall respiratory sensor electrode or electrode array, including connection to pulse generator (List separately in addition to code for primary procedure)"	NP
047XT	"Revision or replacement of chest wall respiratory sensor electrode or electrode array, including connection to existing pulse generator"	NP
048XT	Removal of chest wall respiratory sensor electrode or electrode array            	NP
